Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM

Biomaterials

Volumn 32, Issue 24, 2011, Pages 5558-5567

  Lee, Wen Yu ^a   Wei, Hao Ji ^b   Lin, Wei Wen ^c   Yeh, Yi Chun ^a   Hwang, Shiaw Min ^d   Wang, Jiun Jie ^e   Tsai, Ming Song ^f   Chang, Yen ^b   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d FOOD INDUSTRY RESEARCH AND DEVELOPMENT INSTITUTE   (Taiwan)

^e CHANG GUNG UNIVERSITY   (Taiwan)

^f CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Cell body; Cell therapy; Methylcellulose hydrogel; Myocardial infarction; Tissue regeneration

Indexed keywords

CELL BODIES; CELL THERAPY; METHYLCELLULOSE HYDROGEL; MYOCARDIAL INFARCTION; TISSUE REGENERATION;

DIRECT INJECTION; ECHOCARDIOGRAPHY; HYDROGELS; MAGNETIC RESONANCE IMAGING; POLYMERASE CHAIN REACTION; RESONANCE; STEM CELLS; TISSUE;

CYTOLOGY;

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; BASIC FIBROBLAST GROWTH FACTOR; BETA1 INTEGRIN; ENDOGLIN; HEMOPOIETIC GROWTH FACTOR; HERMES ANTIGEN; METHYLCELLULOSE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR B; SOMATOMEDIN; THY 1 ANTIGEN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

AMNIOTIC FLUID STEM CELL; AMNIOTIC FLUID STEM CELL TRANSPLANTATION; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HUMAN; HUMAN CELL; HYDROGEL; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; UPREGULATION;

AMNIOTIC FLUID; ANIMALS; CELLS, CULTURED; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; HUMANS; HYDROGEL; MAGNETIC RESONANCE IMAGING; MALE; METHYLCELLULOSE; MYOCARDIAL INFARCTION; POLYMERASE CHAIN REACTION; RATS; RATS, INBRED LEW; STEM CELL TRANSPLANTATION; TISSUE THERAPY;

RATTUS;

EID: 79957881448     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.04.031     Document Type: Article

References (34)

1. Segers V.F., Lee R.T. Stem-cell therapy for cardiac disease. Nature 2008, 451:937-942.
2. Wollert K.C., Drexler H. Clinical applications of stem cells for the heart. Circ Res 2005, 96:151-163.
3. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 2007, 25:1015-1024.
4. Padin-Iruegas M.E., Misao Y., Davis M.E., Segers V.F., Esposito G., Tokunou T., et al. Cardiac progenitor cells and biotinylated insulin-like growth factor-1 nanofibers improve endogenous and exogenous myocardial regeneration after infarction. Circulation 2009, 120:876-887.
5. Zhang J., Wilson G.F., Soerens A.G., Koonce C.H., Yu J., Palecek S.P., et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009, 104:e30-41.
6. Lin Y.D., Yeh M.L., Yang Y.J., Tsai D.C., Chu T.Y., Shih Y.Y., et al. Intramyocardial peptide nanofiber injection improves postinfarction ventricular remodeling and efficacy of bone marrow cell therapy in pigs. Circulation 2010, 122:S132-S141.
7. Terrovitis J., Lautamaki R., Bonios M., Fox J., Engles J.M., Yu J., et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol 2009, 54:1619-1626.
8. Terrovitis J.V., Smith R.R., Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
9. Nelson T.J., Martinez-Fernandez A., Yamada S., Perez-Terzic C., Ikeda Y., Terzic A. Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009, 120:408-416.
10. Tsuji H., Miyoshi S., Ikegami Y., Hida N., Asada H., Togashi I., et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 2010, 106:1613-1623.
11. Tsai M.S., Lee J.L., Chang Y.J., Hwang S.M. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod 2004, 19:1450-1456.
12. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25:100-106.
13. Tsai M.S., Hwang S.M., Tsai Y.L., Cheng F.C., Lee J.L., Chang Y.J. Clonal amniotic fluid-derived stem cells express characteristics of both mesenchymal and neural stem cells. Biol Reprod 2006, 74:545-551.
14. Carraro G., Perin L., Sedrakyan S., Giuliani S., Tiozzo C., Lee J., et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 2008, 26:2902-2911.
15. Yeh Y.C., Wei H.J., Lee W.Y., Yu C.L., Chang Y., Hsu L.W., et al. Cellular cardiomyoplasty with human amniotic fluid stem cells: in vitro and in vivo studies. Tissue Eng Part A 2010, 16:1925-1936.
16. Li S.H., Lai T.Y., Sun Z., Han M., Moriyama E., Wilson B., et al. Tracking cardiac engraftment and distribution of implanted bone marrow cells: Comparing intra-aortic, intravenous, and intramyocardial delivery. J Thorac Cardiovasc Surg 2009, 137:1225-1233. e1.
17. Cheng K., Li T.S., Malliaras K., Davis D.R., Zhang Y., Marban E. Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction. Circ Res 2010, 106:1570-1581.
18. Teng C.J., Luo J., Chiu R.C., Shum-Tim D. Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty. J Thorac Cardiovasc Surg 2006, 132:628-632.
19. Yu J., Du K.T., Fang Q., Gu Y., Mihardja S.S., Sievers R.E., et al. The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat. Biomaterials 2010, 31:7012-7020.
20. Miyagi Y., Zeng F., Huang X.P., Foltz W.D., Wu J., Mihic A., et al. Surgical ventricular restoration with a cell- and cytokine-seeded biodegradable scaffold. Biomaterials 2010, 31:7684-7694.
21. Masuda S., Shimizu T., Yamato M., Okano T. Cell sheet engineering for heart tissue repair. Adv Drug Deliv Rev 2008, 60:277-285.
22. Lee W.Y., Chang Y.H., Yeh Y.C., Chen C.H., Lin K.M., Huang C.C., et al. The use of injectable spherically symmetric cell aggregates self-assembled in a thermo-responsive hydrogel for enhanced cell transplantation. Biomaterials 2009, 30:5505-5513.
23. Tang X.L., Rokosh G., Sanganalmath S.K., Yuan F., Sato H., Mu J., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010, 121:293-305.
24. Nicklas J.A., Buel E. An Alu-based, MGB Eclipse real-time PCR method for quantitation of human DNA in forensic samples. J Forensic Sci 2005, 50:1081-1090.
25. Yeh Y.C., Lee W.Y., Yu C.L., Hwang S.M., Chung M.F., Hsu L.W., et al. Cardiac repair with injectable cell sheet fragments of human amniotic fluid stem cells in an immune-suppressed rat model. Biomaterials 2010, 31:6444-6453.
26. Robey T.E., Saiget M.K., Reinecke H., Murry C.E. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol 2008, 45:567-581.
27. Yang M.J., Chen C.H., Lin P.J., Huang C.H., Chen W., Sung H.W. Novel method of forming human embryoid bodies in a polystyrene dish surface-coated with a temperature-responsive methylcellulose hydrogel. Biomacromolecules 2007, 8:2746-2752.
28. Wang C.C., Chen C.H., Hwang S.M., Lin W.W., Huang C.H., Lee W.Y., et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells 2009, 27:724-732.
29. Potapova I.A., Gaudette G.R., Brink P.R., Robinson R.B., Rosen M.R., Cohen I.S., et al. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells 2007, 25:1761-1768.
30. Li T.S., Hayashi M., Liu Z.L., Ito H., Mikamo A., Furutani A., et al. Low angiogenic potency induced by the implantation of ex vivo expanded CD117(+) stem cells. Am J Physiol Heart Circ Physiol 2004, 286:H1236-H1241.
31. Li T.S., Ito H., Hayashi M., Furutani A., Matsuzaki M., Hamano K. Cellular expression of integrin-beta 1 is of critical importance for inducing therapeutic angiogenesis by cell implantation. Cardiovasc Res 2005, 65:64-72.
32. Chavakis E., Aicher A., Heeschen C., Sasaki K., Kaiser R., El Makhfi N., et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 2005, 201:63-72.
33. Hochman J.S., Choo H. Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. Circulation 1987, 75:299-306.
34. Chimenti I., Smith R.R., Li T.S., Gerstenblith G., Messina E., Giacomello A., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010, 106:971-980.